Feasibility and market potential for expanding the SentiMag indication to sentinel lymph node biopsy in melanoma
Lead Participant:
ENDOMAGNETICS LIMITED
Abstract
The novel SentiMag magnetic dye and hand-held magnetometer technique has been successfully applied to the sentinel lymph node biopsy (SLNB) procedure in breast cancer. It overcomes the disadvantages of the current radioisotope based technique - including lack of availability, workflow and handling issues and exposure to radiation.
The benefits of this magnetic technique could potentially be applied to other cancers including malignant melanoma, a high profile cancer with more than 116,000 cases per year in the EU and US alone (WHO), and a rapidly increasing incidence.
This project will explore the clinical feasibility of applying magnetic SLN detection to melanoma.
The benefits of this magnetic technique could potentially be applied to other cancers including malignant melanoma, a high profile cancer with more than 116,000 cases per year in the EU and US alone (WHO), and a rapidly increasing incidence.
This project will explore the clinical feasibility of applying magnetic SLN detection to melanoma.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
ENDOMAGNETICS LIMITED | £54,446 | £ 22,002 |
  | ||
Participant |
||
KING'S COLLEGE LONDON | £94,224 | £ 94,224 |
KING'S COLLEGE LONDON BUSINESS LTD |
People |
ORCID iD |
Quentin Harmer (Project Manager) |